Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Tarsus Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/09/2023 |
SC 13G
| BlackRock Inc. reports a 4.9% stake in TARSUS PHARMACEUTICALS INC |
| 02/08/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2023 |
SC 13G
| TimesSquare Capital Management, LLC reports a 5.4% stake in TARSUS PHARAMACEUTICALS INC. |
| 05/13/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| FLYING L INVESTMENTS XI, LLC reports a 5.9% stake in Tarsus Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G
| PERCEPTIVE ADVISORS LLC reports a 6.4% stake in Tarsus Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G
| Azamian Bobak R. reports a 9% stake in Tarsus Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G
| Ackermann Michael reports a 7.1% stake in Tarsus Pharmaceuticals, Inc. |
| 10/30/2020 |
SC 13G
| Cormorant Asset Management, LP reports a 9.8% stake in Tarsus Pharmaceuticals, Inc. |
| 10/28/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 16.2% stake in Tarsus Pharmaceuticals, Inc. |
| 10/26/2020 |
SC 13G
| RTW INVESTMENTS, LLC reports a 12.8% stake in Tarsus Pharmaceuticals, Inc. |
| 10/23/2020 |
SC 13G
| Frazier Life Sciences IX, L.P. reports a 9.5% stake in Tarsus Pharmaceuticals, Inc. |
|
|